» Articles » PMID: 33574736

Estimation of a Matrix of Heterogeneity Parameters in Multivariate Meta-Analysis of Random-Effects Models

Overview
Date 2021 Feb 12
PMID 33574736
Authors
Affiliations
Soon will be listed here.
Abstract

Multivariate meta-analysis has potential over its univariate counterpart. The most common challenge in univariate or multivariate meta-analysis is estimating heterogeneity parameters in non-negative domains under the random-effects model assumption. In this context, two new multivariate estimation methods are demonstrated; first, by extending the Sidik and Jonkman (2005) univariate estimates to a multivariate setting, and second, by considering an iterative version of the Sidik and Jonkman method, namely, a method developed in Wouhib (2013). These two methods are compared with extended DerSimonian and Laird methods (Jackson et al. 2009; Chen et al. 2012) by using an example and simulation in random-effects multivariate meta-analysis. Finally, the benefits of the proposed estimates are evaluated in terms of precision in estimating vectors of effect sizes and associated covariance matrices via simulation. Also, some limitations and remedies resulting from negative definite matrix in estimating heterogeneity parameters will be discussed.

References
1.
DerSimonian R, Laird N . Meta-analysis in clinical trials. Control Clin Trials. 1986; 7(3):177-88. DOI: 10.1016/0197-2456(86)90046-2. View

2.
Sanchez-Meca J, Marin-Martinez F . Confidence intervals for the overall effect size in random-effects meta-analysis. Psychol Methods. 2008; 13(1):31-48. DOI: 10.1037/1082-989X.13.1.31. View

3.
Jackson D, Riley R, White I . Multivariate meta-analysis: potential and promise. Stat Med. 2011; 30(20):2481-98. PMC: 3470931. DOI: 10.1002/sim.4172. View

4.
Sidik K, Jonkman J . A comparison of heterogeneity variance estimators in combining results of studies. Stat Med. 2006; 26(9):1964-81. DOI: 10.1002/sim.2688. View

5.
Sidik K, Jonkman J . A note on variance estimation in random effects meta-regression. J Biopharm Stat. 2005; 15(5):823-38. DOI: 10.1081/BIP-200067915. View